Peptide toxins secreted by venomous
animals bind to mammalian ion
channel proteins and modulate their function. The high specificity
of these toxins for their target ion channels enables them to serve
as powerful tools for ion channel biology. Toxins labeled with fluorescent
dyes are employed for the cellular imaging of channels and also for
studying toxin-channel and toxin-membrane interactions. Several of
these toxins are cysteine-rich, rendering the production of properly
folded fluorescently labeled toxins technically challenging. Herein,
we evaluate a variety of site-specific protein bioconjugation approaches
for producing fluorescently labeled double-knot toxin (DkTx), a potent
TRPV1 ion channel agonist that contains an uncommonly large number
of cysteines (12 out of a total of 75 amino acids present in the protein).
We find that popular cysteine-mediated bioconjugation approaches are
unsuccessful as the introduction of a non-native cysteine residue
for thiol modification leads to the formation of misfolded toxin species.
Moreover, N-terminal aldehyde-mediated bioconjugation
approaches are also not suitable as the resultant labeled toxin lacks
activity. In contrast to these approaches, C-terminal
bioconjugation of DkTx via the sortase bioconjugation technology yields
functionally active fluorescently labeled DkTx. We employ this labeled
toxin for imaging rat TRPV1 heterologously expressed in Xenopus laevis oocytes, as well as for performing
membrane binding studies on giant unilamellar vesicles composed of
different lipid compositions. Our studies set the stage for using
fluorescent DkTx as a tool for TRPV1 biology and provide an informative
blueprint for labeling cysteine-rich proteins.